When most of the companies are diluting their shares and insiders are selling, KemPharm, Inc. (KMPH) does the opposite.
Insiders are buying and the Board of Directors authorizes a program to repurchase up to $50 million of the Company’s outstanding stock valid through December 31, 2023. It is equivalent to 18% of KemPharm’s current market capitalization.
Because of the short term puts i have 2 approaches for KMPH: dump to 7.17 and then go to 11.45 or bounce from the strong support which it has right now and go to $14.50